Skip to content

Application observation of a new nerve block in hip replacement surgery: a randomized controlled trial

Application observation of a new nerve block in hip replacement surgery: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000034036
Enrollment
Unknown
Registered
2020-06-21
Start date
2020-07-01
Completion date
Unknown
Last updated
2020-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoral neck fracture, Congenital hip dysplasia

Interventions

control group:Femoral nerve block
experimental group:Femoral nerve block + external oblique tendon block

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
55 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1) 2020.07-2020.09 patients undergoing elective hip replacement surgery in our hospital; 2) Male patient; 3) Aged 55~85 years; 4) ASA: I-III grade; 5) Subjects voluntarily participated in the study and signed an informed consent.

Exclusion criteria

Exclusion criteria: 1) Evidence of serious cardiovascular, kidney, blood or liver diseases; 2) Previous history of mental or mental illness; 3) Infection at the puncture site; 4) Difficult communication.

Design outcomes

Primary

MeasureTime frame
Intraoperative amount of sufentanil;Hemodynamic parameters;

Secondary

MeasureTime frame
Anesthesia recovery time;Postoperative laryngeal mask removal time;Postoperative VAS score;Additional amount of analgesics;Postoperative delirium;Postoperative adverse events;

Countries

China

Contacts

Public ContactXu Guanghong

The First Affiliated Hospital of Anhui Medical University

xuguanghong2004@163.com+86 13856949535

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026